3-azidopyrimethamine has been researched along with anthralin in 1 studies
*Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS. [MeSH]
*Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS. [MeSH]
| Studies (3-azidopyrimethamine) | Trials (3-azidopyrimethamine) | Recent Studies (post-2010) (3-azidopyrimethamine) | Studies (anthralin) | Trials (anthralin) | Recent Studies (post-2010) (anthralin) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 982 | 151 | 102 |
| Protein | Taxonomy | 3-azidopyrimethamine (IC50) | anthralin (IC50) |
|---|---|---|---|
| microphthalmia-associated transcription factor isoform 9 | Homo sapiens (human) | 0.2317 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 7 | |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, ND; Griffin, RJ; Irwin, WJ; Reichert, U; Schmidt, R | 1 |
1 other study(ies) available for 3-azidopyrimethamine and anthralin
| Article | Year |
|---|---|
Uptake, cytotoxicity and metabolism of m-azidopyrimethamine and related lipophilic antifolates in SV-K14 human keratinocytes in vivo.
Topics: Animals; Anthralin; Azides; Cell Division; Cell Line, Transformed; Cell Survival; Culture Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Folic Acid Antagonists; Humans; In Vitro Techniques; Keratinocytes; Liver; Methotrexate; Mice; Mice, Hairless; Pyrimethamine; Regression Analysis; Skin | 1991 |